News & Updates

For patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis, treatment with glucagon-like peptide-1 receptor agonists helps reduce the risk of hepatic decompensation, portal hypertension, hepatocellular carcinoma, and liver transplantation, according to a study.

A second pre-eclampsia does not lead to worse outcomes relative to the first occurrence, suggests a study. On the contrary, some clinical features and effects appear to be better in the second event.

Treatment with mycophenolate mofetil (MMF) in combination with prednisolone results in better biochemical remission rates at 24 weeks than the use of azathioprine plus prednisolone in patients with treatment-naïve autoimmune hepatitis (AIH), reports a study.

Many patients with mild-to-moderate COVID-19 experience a resurgence of the virus as well as symptoms after a standard 5-day course of treatment with either VV116 or nirmatrelvir–ritonavir, as shown in a study from China.

Emergency department (ED) attendances in Singapore are increasing, which then leads to a higher input and subsequently to overcrowding. Ambulatory (P3) patients, which account for a substantial number of ED turnout, may be diverted to primary care services that are appropriate for their concerns, suggests a recent study.